netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 Formulary Chapter 5: Infections - Full Section

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

This section advises on the choice of anti-infective agents available at each Trust.  Doctors should refer to local or departmental antibiotic  guidelines for advice regarding specific treatments within specialised  units (including prophylaxis for surgical, medical and dental  procedures). Different antibiotic policies can be found in different  hospitals due to local variations in resistance and antibiotic  susceptibility.

M: Use of this agent only to be initiated under the advice of a  microbiologist or virologist as appropriate.

S: Use of this agent only to be initiated under the advice of a relevant clinical specialist.

05.01 Antibacterial drugs
05.01.01 Penicillins Benzylpenicillin and phenoxymethylpenicillin Penicillinase-resistant penicillins Broad-spectrum penicillins Antipseudomonal penicillins Mecillinams
05.01.02 Cephalosporins, carbapenems and other beta-lactums Cephalosporins Carbapenems Other beta-lactums antibiotics
05.01.03 Tetracyclines
05.01.04 Aminoglycosides
05.01.05 Macrolides
05.01.06 Clindamycin
05.01.07 Some other antibacterials
Fusidic acid
Vancomycin and teicoplanin
05.01.08 Sulphonamides and trimethoprim
05.01.09 Antituberculosis drugs
05.01.10 Antileprotic drugs
05.01.11 Metronidazole and tinidazole
05.01.12 Quinolones
05.01.13 Urinary-tract infections
05.02 Antifungal drugs
05.02.01 Triazole antifungals
05.02.02 Imidazole antifungals
05.02.03 Polyene antifungals
05.02.04 Echinocandin antifungals
05.02.05 Other antifungals
05.03 Antiviral drugs
05.03.01 HIV infection
Nucleoside reverse transcriptase inhibitors
Protease inhibitors
Non-nucleoside reverse transcriptase inhibitors
Other antiretrovirals
Pharmacokinetic enhancers of antiretrovirals
Combination Products
05.03.02 Herpesvirus infections Herpes simplex and varicella-zoster infection Cytomegalovirus infection
05.03.03 Viral hepatitis Chronic hepatitis B Chronic hepatitis C
05.03.04 Influenza
05.03.05 Respiratory syncytial virus
05.04 Antiprotozoal drugs
05.04.01 Antimalarials
Artemether with lumefabtrine
05.04.02 Amoebicides
05.04.03 Trichomonacides
05.04.04 Antigiardial drugs
05.04.05 Leishmaniacides
05.04.06 Trypanocides
05.04.07 Drugs for toxoplasmosis
05.04.08 Drugs for pneumocystis pneumonia
05.05 Anthelmintics
05.05.01 Drugs for threadworms
05.05.02 Ascaricides
05.05.03 Drugs for tapeworm infections
05.05.04 Drugs for hookworms
05.05.05 Schistosomicides
05.05.06 Filaricides
05.05.07 Drugs for cutaneous larva migrans
05.05.08 Drugs for strongyloidiasis